This study highlights the Dianthus™ uHTS platform for biophysical screening of MEK1, a key kinase in the MAPK/ERK pathway. Using Spectral Shift technology, ~5,120 compounds were profiled in single-dose mode, generating ~250,000 data points per day.

Download the application note to learn more about:

• Ultra-high-throughput biophysical screening enabled by Spectral Shift technology

• Rapid identification of high-affinity hits from large compound libraries

• A low sample consumption biophysical method with broad applicability across diverse target classes

 

     Sponsored by